![](/img/cover-not-exists.png)
Two phase I, pharmacokinetic, and pharmacodynamic studies of DFP-10917, a novel nucleoside analog with 14-day and 7-day continuous infusion schedules
Sankhala, Kamalesh, Takimoto, Chris H., Mita, Alain C., Xiong, Henry, Rodón, Jordi, Mehrvarz Sarshekeh, Amir, Burns, K., Iizuka, Kenzo, Kopetz, ScottLanguage:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0602-0
Date:
April, 2018
File:
PDF, 857 KB
english, 2018